Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: Ditchdigger who wrote (27779)	1/9/2002 6:53:15 PM
From: Sergio H	Read Replies (1) \| Respond to of 29382

Ditch, I think that there are currently over 500 drugs in late stage development awaiting FDA approval. These pending applications represent products that will turn many biotech and pharma companies into profitable entities. The DRG may have bottomed out. Looks like a bottom Bollinger play to me. The BTK is on the other side of the 200 day MA and is about to test support. Good entry point for either index if you believe in these sectors. Still keeping an eye on SOX and YLS. SOX is holding above 200 day MA while YLS needs a new try. Your RBOT is tailor-made for daytrading. Very volitile lately. Sergio